549 Followers on Owler

ALX Oncology

is a California-based biotechnology company that researches and develops immuno-oncology therapies for the treatment of cancer... Read more
OverviewCompetitorsAcquisitionsFundingNews & Insights

ALX Oncology

is a California-based biotechnology company that researches and develops immuno-oncology therapies for the treatment of cancer... Read more
ALX Oncology CEO: Jason Lettmann

CEO

Jason Lettmann

CEO Approval Rating

82/100

2015

PublicIndependent CompanyNASDAQALXO

Pharmaceuticals & Biotechnology
Biotechnology
2836 NAICS listing

Annual Revenue
$1.2M
Employees
40
Funding
$706.6M
Acquisitions
1

News

Layoffs
Mar 05, 2025
SFGate
Bay Area biotech firm once worth more than $4B lays off 30% of staff
Conference Presentation
Nov 26, 2024
Benzinga
ALX Oncology to Participate in the Piper Sandler 36th Annual Healthcare Conference

ALX Oncology Competitors

1Precigen
2Zymeworks
3Numab
Unlock more competitors

Trending Companies